The largest database of trusted experimental protocols

13 protocols using ypd broth

1

Candida albicans Infection Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
C. albicans SC5314 were grown in YPD broth (Difco laboratories, Detroit, MI, USA) and stock cultures were stored at −80 °C. The frozen stocks were first grown on YPD plates and kept at 4 °C. Prior to each experiment, a stock inoculum suspension of Candida was prepared in YPD broth and incubated at 30 °C with shaking at 200 rpm for 12 h. The culture was washed twice with sterile 1X phosphate buffered saline (PBS), counted with a hemocytometer, and diluted with PBS to get the desired concentration of 3.5 × 105 cfu/mL. 100 µL was injected intravenously (IV) into each mouse via the tail vein. The desired infection dose was confirmed by plating 10-fold dilutions of the inoculum on YPD plates, which were incubated at 37 °C for 24 h to yield viable counts (cfu) of yeast colonies [12 (link)].
+ Open protocol
+ Expand
2

Chronological Lifespan Assay in Yeast

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains were grown at 30°C in YPD with 2% glucose, or YP medium supplemented with 2% glycerol (YPG) or 3% oleic acid as carbon sources. For CLS experiments, minimal medium (SD) with 2% glucose and 0.67% yeast nitrogen base supplemented with amino acids was used. All strains were routinely grown in 5 ml of YPD broth (Difco Laboratories) at 30°C overnight, washed in phosphate buffered saline (PBS) and then -inoculated in 100 ml of SD with an OD600 of 0.2 at day 0. Shake cultures were grown at 30°C (200rpm), and one- ml samples were then removed from each strain daily at 1–9 days. Each aliquot of 400–600 cells was transferred to two YPD agar plates. Colony counts (% survival) were determined after a 48 h incubation. Data are indicated as % survival compared to the original inocula (Chen et al., 2012 (link)).
+ Open protocol
+ Expand
3

Bacterial and Fungal Strain Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial and fungal strains (S2 Table in S1 File) used in this study were clinical isolates obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), the Centers for Disease Control and Prevention (CDC) and Biodefense and Emerging Infections Research Resources Repository (BEI Resources) (Manassas, VA, USA). RPMI 1640 (Thermo Fisher Scientific, Waltham, MA), YPD broth, YPD agar, cation adjusted Mueller-Hinton broth, brain heart infusion broth, and lactobacilli MRS broth (Becton, Dickinson and Company, Franklin Lakes, NJ) were purchased from commercial vendors. Phosphate buffered saline was purchased from Fisher Scientific (Waltham, MA). Yeast extract, L-cysteine, vitamin K, 3-(N-Morpholino)propanesulfonic acid (MOPS) and hemin were obtained from Sigma-Aldrich (St. Louis, MO). Human colorectal adenocarcinoma epithelial cells (Caco-2) (ATCC HTB-37), and monkey kidney epithelial cells (Vero) (ATCC CCL-81-VHG) were obtained from the American Type Culture Collection (ATCC) (Manassas, VA, USA).
+ Open protocol
+ Expand
4

Fermentation of Panax notoginseng Root by Saccharomyces cerevisiae

Check if the same lab product or an alternative is used in the 5 most similar protocols
S. cerevisiae CMCC17452 was cultivated with YPD broth (Becton, Dickinson and Company, Sparks, MD, USA) at 28 °C for 48 h. P. notoginseng root (PNR) and pure water were were mixed to a ratio of 1 to 10 before sterilization for 15 min at 121 °C. S. cerevisiae CMCC17452 was inoculated into PNR solution at a concentration of 5% (V/V) and fermented at 28 °C for 24 h. The PNR solution without S. cerevisiae CMCC17452 was used as a blank control. Samples were centrifuged and the supernatant collected for analysis and named fermented P. notoginseng root liquid (FPNR) and water-extracted P. notoginseng root liquid (WPNR).
+ Open protocol
+ Expand
5

Evaluating Probiotic Effects on C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
A highly toxigenic C. difficile (HTCD) strain: VPI10463 (ATCC, Manassas, VA) and a clinical isolate TL24 (University of Virginia)28 (link) that is binary toxin secreting (BI) were used in all experiments. Saccharomyces boulardii (Swanson Health Products, Fargo, ND), Lactobacillus acidophilus (Swanson Health Products), Lactobacillus casei ss. shirtota (Yakult Honsha, Tokyo, Japan), Lactobacillus rhamnosus (Swanson Health Products), and Bifidobacterium longum ss. infantis (Align, Proctor and Gamble, Cincinnati, OH) were isolated from commercial probiotic products. Strains were cultured under anaerobic conditions using a Bactron anaerobic chamber (Sheldon Manufacturing, United States) for 48 h until they reached stationary phase. C. difficile strains and B. longum were grown using BHI medium, Lactobacillus strains using MRS broth, Saccharomyces using YPD broth (Becton Dickinson, United States).
+ Open protocol
+ Expand
6

Culturing Probiotic Lactobacilli and Candida glabrata

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both probiotic lactobacilli strains were routinely cultured on de Man, Rogosa and Sharpe (MRS) agar (Hi-Media, Mumbai, India) and incubated anaerobically for 48 h at 37°C. Subsequently, lactobacilli strains were inoculated into MRS broth (Hi-Media) and incubated anaerobically for 24 h at 37°C in an orbital shaker (180 rev min−1). All of the C. glabrata strains were cultured on Yeast Extract-Peptone-Dextrose (YPD) agar (Becton Dickinson, Franklin Lakes, NJ) and incubated aerobically for 24 h at 37°C. Candida glabrata colonies were transferred into YPD broth (Becton Dickinson) and incubated aerobically for 24 h at 37°C in an orbital shaker (180 rev min−1).
+ Open protocol
+ Expand
7

Preparation of Cryptococcus and Candida Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
C. neoformans strains H99 (serotype A, mating type α) H99γ (serotype A, mating type α, an interferon-gamma producing strain derived from C. neoformans H9925 (link)), and H99 calcineurin mutant (cna1Δ, a kind gift from Dr. Joseph Heitman, Duke University) were recovered from 15% glycerol stocks stored at −80 °C and maintained on yeast-extract-peptone-dextrose (YPD) agar (1% yeast extract, 2% peptone, 2% dextrose, and 2% Bacto agar). Candida albicans strain SC5314 was maintained on YPD media. Staphylococcus aureus strain UAMS-1 was maintained on Luria-Bertani (LB) agar. Yeast cells were grown for 15–17 h at 30 °C with shaking in YPD broth (Becton Dickinson and Company, Sparks, MD), collected by centrifugation (2500 × g), washed three times with sterile phosphate-buffered saline (PBS), and viable yeast quantified using trypan blue dye exclusion in a hemacytometer. S. aureus was grown for 12 h at 37 °C with shaking in LB broth (Fisher Scientific, Waltham, MA), collected by centrifugation (2500 × g) and washed three times with sterile PBS. Yeast cells were heat-killed at 65 °C for 30 min. S. aureus was heat-killed at 95 °C for 1 h. All cultures were confirmed dead by culturing for growth on LB or YPD agar.
+ Open protocol
+ Expand
8

Cultivation and Quantification of C. gattii

Check if the same lab product or an alternative is used in the 5 most similar protocols

C. gattii strain R265 (VGII molecular genotype) was recovered from 15% glycerol stocks stored at −80°C. The strain was maintained on yeast extract peptone dextrose (YPD) agar (1% yeast extract, 2% peptone, 2% dextrose, and 2% bacto agar). Yeast cells were grown in YPD broth (Becton Dickinson and Company, Sparks, MD) for about 16–18 hours at 30°C with constant shaking. Yeast cells were collected by centrifugation and washed with sterile phosphate buffered saline (PBS) for further protein extraction. Quantification of viable yeast was performed using trypan blue dye exclusion in a hemocytometer for pulmonary infection.
+ Open protocol
+ Expand
9

Antifungal Susceptibility of Candida Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolates used in this study are part of a strain collection deposited at the Department of Translational Research, University of Pisa, and stored in YPD broth (yeast extract, peptone, dextrose) (Difco BD, Italy) supplemented with 40% glycerol at −20 and −80°C. Clinical isolates of Candida spp. were collected at the Mycology Unit, Azienda Ospedaliero-Universitaria Pisana (Pisa, Italy), identified by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Germany), and tested for antifungal susceptibility according to EUCAST guidelines (http://eucast.org/clinicalbreakpoints/). The strains used in this study were clinical isolates selected on the basis of caspofungin sensitivity and two reference strains (Table 4). For each experiment, cells were inoculated in YPD broth and incubated overnight at 30°C. Next, cells were washed twice in sodium phosphate buffer (NaPB) (0.01 M [pH 7]), and diluted at the desired concentration.
+ Open protocol
+ Expand
10

Isolation and Purification of Candida albicans Secreted Aspartic Proteases

Check if the same lab product or an alternative is used in the 5 most similar protocols
SAPs were isolated as previously described65 (link),66 (link). Briefly, C. albicans was grown in YPD broth (BD, Sparks, 21152) for 24 h at 26 °C. Cells were removed by centrifugation (8500 r.p.m./6800 × g, 5 min, 4 °C) and the supernatants containing SAPs were concentrated 25 times in a Pierce Protein Concentrator (10 kDA MWCO, #88535, Thermo Fisher Scientific, Waltham, MA). Concentrated SAPs were then purified by passage through a Pierce Strong Anion Exchange Spin Column (#90011, Thermo Fisher Scientific, Waltham, MA). 20 mM Tris/HCl (pH 6.0) was used for column binding and 2 M Tris/HCl (pH 6.0) was used for elution. SAPs were then concentrated again as described above. SAP concentration was determined using a BCA protein assay kit (Thermo Fisher Scientific).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!